|
Dec21
|
Almost the last week of the year. So here's this weeks list of pharmaceutical news that didn't make it into the site. Have a great weekend!
|
|
Dec21
|
Company Name, Symbol, Share Price, ChangeAbbott Laboratories' (NYSE:ABT) - $58.26 +0.66 (+1.15%) AstraZeneca (NYSE:AZN) - $44.13 +0.18 (+0.41%) Bristol-Myers Squibb (NYSE:BMY) - $27.98 +0.09 (+0.32%) Eli Lilly & Co. (NYSE:LLY) - $54.23 +1.00 (+1.88%) GlaxoSmithKline(NYSE:GSK) - $50.91 +0.18 (+0.35) Merck & Co. (NYSE:MRK) -...
Continue Reading
|
|
Dec20
|
The U.S. Food and Drug Administration announced that it has finalized a new ruling that will require manufactures of certain contraceptive gels, foams, films and inserts to have a warning that the products do not protect against sexually transmitted diseases,...
Continue Reading
|
|
|
The U.S Food and Drug Administration has announced that it has issued tentative approval for a generic version of Viread (tenofovir disoproxil fumarate). Viread is a drug that is used in combination with other antriretroviral agents in the treamtent of...
Continue Reading
|
|
|
Wyeth Pharmaceuticals Inc. may have thought that their biggest drug, Effexor XR, was safe from competition for a while but Sun Pharmaceuticals may be cutting into the revenue pie. Wyeth holds the patent on Effexor XR capsules until July 2010 which...
Continue Reading
|
|
Dec19
|
GlaxoSmithKline(NYSE:GSK) has acquired Reliant Pharmaceuticals following the US Federal Trade Commission's early termination of the waiting period required by U.S. anitrust law.The acquisition adds Reliant's cardiovascular drugs to the GlaxoSmithKline pipeline. These include Lovaza (omega-3-acid ethyl esters) and FDA approved...
Continue Reading
|
|
Dec18
|
Dr. Roberto Minutolo of the Second University of Naples reports in the American Journal of Kidney Diseases that switching one hypertension pill from morning to bedtime may normalize blood pressure in patients at higher right of heart and kidney disease.In...
Continue Reading
|
|
|
A collaborative Brazillian study between the Vitória Municipal Addiction Treatment Center (Dr. Furieri); and the Department of Physiological Sciences, Health Science Center, Federal University of Espírito Santo (Dr. Nakamura-Palacios) found that Gabapentin reduced alcohol craving and consumption.A randomized, double-blind, placebo controlled...
Continue Reading
|
|
|
Forest Laboratories Inc. (NYSE:FRX) and Mylan Inc.(NYSE:MYL) have received U.S. Food and Drug Administration approval for their beta blocker Bystolic.Bystolic, indicated for the treatment of hypertension, is a one daily medication that can be used in conjunction with other high blood...
Continue Reading
|
|
Dec17
|
GlaxoSmithKline has announced that clinical trials on Tykerb, a drug that fights breast cancer, also helps fight the cancer after it has spread to the brain.The randomized study, an extention of an earlier Phase II study involving 49 patients, showed...
Continue Reading
|
|
|
GlaxoSmithKline announced that it received a FDA complete response letter with regards to its application for new drug status for Cervarix, a cervical cancer vaccine. A complete response letter is issued when the FDA has completed review of the file but still...
Continue Reading
|
|
Dec15
|
Company Name, Symbol, Share Price, ChangeAbbott Laboratories' (NYSE:ABT) - $57.51 -0.87 (-1.49%) AstraZeneca (NYSE:AZN) - $45.34 -1.10 (-2.37%) Bristol-Myers Squibb (NYSE:BMY) - $28.08 -0.73 (-2.53%) Eli Lilly & Co. (NYSE:LLY) - $53.71 -0.47 (-0.87%) GlaxoSmithKline(NYSE:GSK) - $53.00 -0.93 (-1.72) Merck & Co. (NYSE:MRK) -...
Continue Reading
|
|
Dec14
|
Another week and more stories that PharmaGazette was unable to write about. Here is a varied list of what else happened this week in pharmaceutical and health news.Interesting Articles for Week Ending Dec 14Men carry breast cancer genes, too from Yahoo...
Continue Reading
|
|
|
The FDA has voted against making Mevacor available over the counter. This drug, used to treat high cholesterol patients, is part of a class of medications called statins. Statins are HMG-COA reductase inhibtors and helps lower cholesterol in people who...
Continue Reading
|
|
|
Wyeth Pharmaceuticals announced that the results of two clinical Phase III trials of Pristiq (desvenlafaxine) showed that patients experienced a statistically significant reduction in their symptoms of major depression.Adult patients who received a 50 mg/day dosage for the treatment of...
Continue Reading
|
|
Dec13
|
U.S. Food and Drug Administration today issued tentative approval for Mylan Pharmaceuticals Inc’s Lamotrigine tablets. Lamotrigine is the generic version of GlaxoSmithKline's Lamictal tablets which is an anticonvulsant drug used to treat partial seizures associated with epilepsy. It is also...
Continue Reading
|
|
|
Last but not least is Schering-Plough who falls 15th on the r&d budget list ($1.65 bn EUR) and 16th in over all sales for 2006. After a number of bad years Schering has put itself back in the running with...
Continue Reading
|
|
|
Abbott Laboratories' (NYSE:ABT) finds itself at #14 for research and development budget with $1.71 bn EUR and #9 for sales in 2006. Abbott did issue a recall on blood pressure monitors in September and received FDA approval for Niaspan indicated as...
Continue Reading
|
|
|
Bristol-Myers Squibb (NYSE:BMY), #12 in sales in 2006 and #13 in R&D in 2006 with $2.32 bn EUR budget still hasn’t managed to pull out of the mess of the last few years. While it has a few strategic partnerships with...
Continue Reading
|
|
|
Wyeth finds itself in the #12 spot of 15 for research and development budget with $2.35 bn EUR and #10 in overall sales for 2006. 2007 was a tough year for the company as its 3 big drug candidates, bifeprunox,...
Continue Reading
|
|
Dec12
|
Standing 11th with a R&D expenditure of $2.76 bn EUR and 13th in over all sales, Eli Lily (NYSE:LLY) is pinning its hopes on prasurgel, an anti-clotting drug that outperformed Plavix in reducing heart attacks. However, the drug was also...
Continue Reading
|
|
|
Bayer, the German based company logged in at 10th in R&D and 11th in over all sales for 2006. Canadian researchers stopped a study on Trasylol because of the risk of death but Bayer received FDA supplemental New Drug approval for...
Continue Reading
|
|
|
Amgen managed a 9th place sport in top R&D research spending and a 14th place spot for sales in 2006. Not an overly good year for the company as it had to deal with the fallout from the increased box...
Continue Reading
|
|
|
Swiss pharmaceutical AstraZeneca (NYSE:AZN) was 8th on the list of R&D research spending with a 2006 expenditure of $2.95 bn EUR and 7th for overall sales in 2006. AstraZeneca saw its Seroquel XR for schizophrenia get FDA approval this year...
Continue Reading
|
|
|
U.S. based Merck & Co. (NYSE:MRK) was 8th in total sales and #7 ($3.62 bn EUR)in R&D spending in 2006. Merck has had success with the U.K mandating HPV for all school age girls and its vaccine, Gardasil, is in the...
Continue Reading
|
|
|
Novartis AG (NYSE:NVS), rated #4 in sales found itself at #6 ($4.06 bn EUR) for total research and development budget in 2006. 2007 had goods news from Novartis with FDA and EU approval of osteoporosis drug, Aclasta/Reclast and hypertension drug, tekturna, but...
Continue Reading
|
|
Dec11
|
Roche of Switzerland lands at #5 ($4.09 Eur) in the top 15 R&D spenders and #6 in overall sales. The company spent 2007 restructuring its research facilities and divided R&D into 5 categories: oncology, virology, inflammation, metabolism and the central nervous...
Continue Reading
|
|
|
Sanofi-aventis (EPA: SAN), the U.K based pharmaceutical, was rated #5 in overall sales and 4th on the list of top R&D spenders in 2006. Sanofi has has trouble over the last year with its drug Acomplia failing to get U.S. Food...
Continue Reading
|
|
|
GlaxoSmithKline plc (NYSE: GSK), ranked #3 in sales, invested 10% more in 2006 into research and development. The company experienced a huge hit when the FDA increased the warning label strength on the blockbuster drug Avandia. Add in the fact...
Continue Reading
|
|
|
U.S. based Johnson & Johnson found itself in the top 5 R&D spenders among pharmaceuticals with a 15.5% increase over the previous year's spending which translates into $5.4 bn Eur. Ranked #1 in sales, Johnson & Johnson expect 21 new...
Continue Reading
|
|
|
The U.S based company, Pfizer Inc. (NYSE: PFE) which is ranked #2 in sales, invested $5.8 bn EUR in 2006 into research and development. In 2007 the company made the major decision to invest in biotech drugs which are less susceptible to generic...
Continue Reading
|
|
|
The 2007 edition of the European Commission's annual report of research and development spending places Pfizer Inc. at the top of the heap outspending all other industries.Pharmaceuticals and biotechnology became the top R&D spenders beating out the technology heardware and...
Continue Reading
|
|
Dec10
|
Final assessment of two small, long-term, open studies on patients with gastro-esphogeal reflux disease (GERD) comparing anti-reflux surgery with either Nexium or omeprazole was announced by the U.S. Food and Drug Administration. The FDA concluded that "long-term use of these drugs is...
Continue Reading
|
|
Dec 8
|
Columbia scientists believe they have figured out how the BRCA1 gene leads to a hereditary form of breast cancer.While collaborating with Swedish scientists, the team discovered a gene, named PTEN, is involved in genetic miscues that result in cancer. If the...
Continue Reading
|
|
Dec 7
|
Company Name, Symbol, Share Price, ChangeAbbott Laboratories' (NYSE:ABT) - $58.22 +0.07 (+0.12%) AstraZeneca (NYSE:AZN) - $47.00 +0.46 (+0.99%) Bristol-Myers Squibb (NYSE:BMY) - $29.23 +0.15 (+0.52%) Eli Lilly & Co. (NYSE:LLY) - $54.30 +0.37 (+0.69%) GlaxoSmithKline(NYSE:GSK) - $53.27 +0.42 (+0.79) Merck & Co. (NYSE:MRK) -...
Continue Reading
|
|
|
The first week of the last month of the year is over and of course there was a ton of interesting stories that PharmaGazette just didn't get the chance to cover. So, as usual, I'll list the top 10 or so...
Continue Reading
|
|
|
Bristol-Myers Squibb (NYSE:BMY) announced Wednesday that it will be restructuring to focus more on biotechnology and specialty drugs and that it expect to cut 10 percent of its workforce by 2010.The restructuring is to "increase profitability," the global pharmaceuticals giant said...
Continue Reading
|
|
|
Once again there's a study telling us that cell phones cause an increase in tumor risk. This time it's from a study by Israeli scientists that published their research in the American Journal of Epidemiology.An extract of the report puts the...
Continue Reading
|
|
|
CORONA, Calif., Dec. 6 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that it has reached a settlement with Novartis Pharmaceuticals Corporation, Novartis Pharma AG, Novartis AG, Novartis International Pharmaceutical Ltd., and Proterra AG...
Continue Reading
|
|
|
Desmopressin, a drug that limits the amount of water that is eliminated in the urine and also is used to prevent and control excessive thirst, urination and dehydration due to injury, surgery and certain medical conditions has received a U.S....
Continue Reading
|
|
Dec 6
|
A U.S. Food and Drug Administration advisory committee voted unanimously to recommend approval of tetrabenzine for chorea associated with Huntington disease (HD). If approved it would be the first drug in the U.S. approved for the treatment of chorea. The...
Continue Reading
|
|
|
Bivalirudin, brand name Angiomax, a "direct thrombin inhibitor", is used to prevent blood clots and keep blood flowing freely during cardiac procedures such as bypass surgery. In a study funded by The Medicines Company of Parsippany, N.J. and the Danish...
Continue Reading
|
|
Dec 5
|
FiercePharma has compiled a list of the top 10 drugs to have who have had approval either withdrawn or been forced to add stronger warning labels, by the FDA, with respect to their pharmaceutical products. The list is based on 2006 worldwide...
Continue Reading
|
|
|
September 2007The U.S Food and Drug Administration alerted healthcare professionals and consumers of the possible side effects of Fentora (fentanyl buccal) after reports of deaths and other adverse events.Fentora, an opiod pain medication, is used only for the treatment of...
Continue Reading
|
|
|
Proposed in February and approved in July, Xolair (omalizumab) will be sporting a new, upgraded black box warning as per U.S. Food and Drug Administration recommendation. The warning will emphasize that Xolair, an injectable, used to treat patients with asthma related...
Continue Reading
|
|
|
March 2007 had the U. S Food and Drug Administration asking Novartis Pharmaceuticals to voluntarily discontinue marketing of Zelnorm (tegaserod). The request comes on the heels of the recently identified finding of serious cardiovascular adverse events, hear problems, associated with...
Continue Reading
|
|
|
In June 2007, during congressional hearings, the U.S. Food and Drug Administration revealed that it has called for the strongest black box warning possible on Actos.After reviewing postmarketing adverse event reports, the FDA that Actos (pioglitazone), approved to treat Type 2...
Continue Reading
|
|
|
In May, 2007 the U. S. Food and Drug Administration updated the black box warning on 36 antidepressants to include the increased risk of suicidal thinking and behavior, known as suicidality, in young adults between the ages of 18 and...
Continue Reading
|
|
Dec 4
|
Novartis AG's cancer drug, Gleevec, has been reworked to avoid a rare heart related side effect and to more specifically target a type of stomach cancer according to researchers at Rice University in Houston and University of Texas M.D. Anderson...
Continue Reading
|
|
|
Scientists at the Blanchette Rockefeller Neurosciences Institute have found that Bryostatin, a cancer drug, enhanced the formation of new connections in the brains of rats during memory storage. They believe that the drug could potentially increase normal memory capacity in...
Continue Reading
|
|
|
Michala Riggle might be only 10 years old but she's got the heart and spirit of a wise old soul. After her brother's autism improved when he received an injection of an amnio acid and an antioxidant called Glutathione, as well at...
Continue Reading
|
|
|
Children with autism spectrum disorder may have improved behavior with the onset of a fever of at least 100.4F however, the behavioral change is transient.Dr. Andrew W. Zimmerman from the Kennedy Krieger Institute in Baltimore and colleagues assessed the parent-reported...
Continue Reading
|
|
|
MammaPrint, a breast cancer test invented and developed by the Dutch company Agendia, was named one of Time magazine's Best Invention's of 2007.The test, called "Cancer's Crystal Ball" gives additional information on a patient's tumor to aid in deciding the...
Continue Reading
|
|
|
U.S researchers have found that cancerous cells are 70 percent softer than non-cancerous ones by using an atomic force microscope.The nano-scale tool measured a difference in elasticity of cells in lung, breast and pancreatic cancers and this difference could help...
Continue Reading
|
|
Dec 3
|
The U.S. Food and Drug Administration has approved Diovan (valsartan) for use on children between the ages of six and sixteen following a priority review. Diovan is an angiotensin receptor blocker (ARB). The drug has already been previously approved for use...
Continue Reading
|
|
|
VeriChip Corporation announced today that it will unveil details and plans to build a prototype self-contained implantable bio-sensing device included on a microchip that will have the ability to measure glucose levels.If this prototype gets off the ground and actually...
Continue Reading
|
|
|
Researchers at the Salk Institute for Biological Studies in La Jolla, Calif. believe that the diabetes drug, Avandia, may increase bone thinning, osteoporosis, which may explain why diabetics have an increased risk of fractures.Research has found the possibility that long-term...
Continue Reading
|
|
|
Antibiotic development could be revolutionized by a new genetic decoy system according to British scientists.Scientist from the John Innes Centre stated that they have proven that by taking a short piece of DNA from a bacterium and delivering it within...
Continue Reading
|
